Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0063 | 1 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0044 | 0.0063 | 0.0063 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0156 | 0.137 | 0.137 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0044 | 0.0063 | 0.0268 |
Echinococcus multilocularis | geminin | 0.0098 | 0.0692 | 0.0692 |
Echinococcus multilocularis | thymidine phosphorylase | 0.0895 | 1 | 1 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.0895 | 1 | 1 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0044 | 0.0063 | 1 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0039 | 0 | 0.5 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.0895 | 1 | 1 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0044 | 0.0063 | 0.0063 |
Echinococcus granulosus | geminin | 0.0098 | 0.0692 | 0.0692 |
Schistosoma mansoni | hypothetical protein | 0.0098 | 0.0692 | 0.2957 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.0253 | 0.2497 | 0.5 |
Loa Loa (eye worm) | MBCTL1 | 0.0044 | 0.0063 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0239 | 0.2341 | 1 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0044 | 0.0063 | 0.0063 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0156 | 0.137 | 0.137 |
Schistosoma mansoni | hypothetical protein | 0.0098 | 0.0692 | 0.2957 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0044 | 0.0063 | 0.0063 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
pKb (functional) | = 9.6 | Antagonist activity at rat AT1 receptor expressed in CHO cells assessed as angiotensin 2-evoked increase in intracellular calcium level | ChEMBL. | 18191398 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.